EZH2 and prostate carcinoma: A recent study revealed that lincRNA-p21 could enhance EZH2-pS21 through inhibiting the EZH2-HOTAIR interaction, leading to PRC2 disruption in prostate cancer cells 123, indicating that lincRNA-p21 determines the outcomes of EZH2-mediated gene expression (Figure 2B).